Literature DB >> 11158770

Macrolide resistance in Peptostreptococcus spp. mediated by ermTR: possible source of macrolide-lincosamide-streptogramin B resistance in Streptococcus pyogenes.

M Reig1, J Galan, F Baquero, J C Perez-Diaz.   

Abstract

Eighty percent (21 of 26) of macrolide-resistant Peptostreptococcus strains studied harbored the ermTR gene. This methyltransferase gene is also the most frequently found gene among macrolide-lincosamide-streptogramin B-resistant Streptococcus pyogenes strains. Transfer of the ermTR gene from Peptostreptococcus magnus to macrolide-susceptible S. pyogenes strains indicates that this resistance determinant may circulate among gram-positive aerobic and anaerobic species of the oropharyngeal bacterial flora.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11158770      PMCID： PMC90342          DOI： 10.1128/AAC.45.2.630-632.2001

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  16 in total

1.  Prevalence and mechanisms of macrolide resistance in clinical isolates of group A streptococci from Ontario, Canada.

Authors:  J C De Azavedo; R H Yeung; D J Bast; C L Duncan; S B Borgia; D E Low
Journal:  Antimicrob Agents Chemother       Date:  1999-09       Impact factor: 5.191

2.  Macrolide resistance phenotypes and mechanisms of resistance in Streptococcus pyogenes in La Rioja, Spain.

Authors:  A Portillo; M Lantero; M J Gastañares; F Ruiz-Larrea; C Torres
Journal:  Int J Antimicrob Agents       Date:  1999-10       Impact factor: 5.283

3.  Cloning and analysis of ermG, a new macrolide-lincosamide-streptogramin B resistance element from Bacillus sphaericus.

Authors:  M Monod; S Mohan; D Dubnau
Journal:  J Bacteriol       Date:  1987-01       Impact factor: 3.490

4.  Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland.

Authors:  H Seppälä; A Nissinen; Q Yu; P Huovinen
Journal:  J Antimicrob Chemother       Date:  1993-12       Impact factor: 5.790

5.  Complete nucleotide sequence and transcription of ermF, a macrolide-lincosamide-streptogramin B resistance determinant from Bacteroides fragilis.

Authors:  J L Rasmussen; D A Odelson; F L Macrina
Journal:  J Bacteriol       Date:  1986-11       Impact factor: 3.490

6.  Transferable Tet M in Fusobacterium nucleatum.

Authors:  M C Roberts; J Lansciardi
Journal:  Antimicrob Agents Chemother       Date:  1990-09       Impact factor: 5.191

7.  Resistance of Peptostreptococcus spp. to macrolides and lincosamides: inducible and constitutive phenotypes.

Authors:  M Reig; A Moreno; F Baquero
Journal:  Antimicrob Agents Chemother       Date:  1992-03       Impact factor: 5.191

8.  Detection of erythromycin-resistant determinants by PCR.

Authors:  J Sutcliffe; T Grebe; A Tait-Kamradt; L Wondrack
Journal:  Antimicrob Agents Chemother       Date:  1996-11       Impact factor: 5.191

9.  Tetracycline resistance in Peptostreptococcus species.

Authors:  M C Roberts
Journal:  Antimicrob Agents Chemother       Date:  1991-08       Impact factor: 5.191

10.  Cloning and sequence analysis of ermQ, the predominant macrolide-lincosamide-streptogramin B resistance gene in Clostridium perfringens.

Authors:  D I Berryman; M Lyristis; J I Rood
Journal:  Antimicrob Agents Chemother       Date:  1994-05       Impact factor: 5.191
View more
  9 in total

1.  Detection of inducible clindamycin resistance in beta-hemolytic streptococci by using the CLSI broth microdilution test and erythromycin-clindamycin combinations.

Authors:  Jason E Bowling; Aaron E Owens; M Leticia McElmeel; Letitia C Fulcher; Monica L Herrera; Brian L Wickes; James H Jorgensen
Journal:  J Clin Microbiol       Date:  2010-04-14       Impact factor: 5.948

Review 2.  Anaerobic infections: update on treatment considerations.

Authors:  Elisabeth Nagy
Journal:  Drugs       Date:  2010-05-07       Impact factor: 9.546

3.  Life-threatening invasive Helcococcus kunzii infections in intravenous-drug users and ermA-mediated erythromycin resistance.

Authors:  Patrick C Y Woo; Herman Tse; Samson S Y Wong; Cindy W S Tse; Ami M Y Fung; Dorothy M W Tam; Susanna K P Lau; Kwok-yung Yuen
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

4.  Emergence of group A streptococcus strains with different mechanisms of macrolide resistance.

Authors:  Edouard Bingen; Roland Leclercq; Frédéric Fitoussi; Naïma Brahimi; Brigitte Malbruny; Dominique Deforche; Robert Cohen
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

5.  Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B streptococcus isolates from Ontario, Canada.

Authors:  J C de Azavedo; M McGavin; C Duncan; D E Low; A McGeer
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

6.  New genetic element carrying the erythromycin resistance determinant erm(TR) in Streptococcus pneumoniae.

Authors:  Romina Camilli; Maria Del Grosso; Francesco Iannelli; Annalisa Pantosti
Journal:  Antimicrob Agents Chemother       Date:  2007-12-10       Impact factor: 5.191

7.  Prevalence, characteristics, and molecular epidemiology of macrolide and fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae at five tertiary-care hospitals in Korea.

Authors:  Jeong Hwan Shin; Hee Jung Jung; Hye Ran Kim; Joseph Jeong; Seok Hoon Jeong; Sunjoo Kim; Eun Yup Lee; Jeong Nyeo Lee; Chulhun Ludgerus Chang
Journal:  Antimicrob Agents Chemother       Date:  2007-05-14       Impact factor: 5.191

8.  Antibiotic Susceptibility and Resistance Genes in Oral Clinical Isolates of Prevotella intermedia, Prevotella nigrescens, and Prevotella melaninogenica.

Authors:  Yormaris Castillo; Nathaly Andrea Delgadillo; Yineth Neuta; Andrés Hernández; Tania Acevedo; Edwin Cárdenas; Andrea Montaño; Gloria Inés Lafaurie; Diana Marcela Castillo
Journal:  Antibiotics (Basel)       Date:  2022-07-04

Review 9.  Antibiotic Resistance and Mechanisms of Pathogenic Bacteria in Tubo-Ovarian Abscess.

Authors:  Huanna Tang; Hui Zhou; Runju Zhang
Journal:  Front Cell Infect Microbiol       Date:  2022-07-27       Impact factor: 6.073
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.